LAURA MASON: Open Payments
NPI 1821056698 · GRAND ISLAND, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$537 in 18 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $117 · 2025 $537
Food & beverage: $537
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 9 | $147 |
| REVANCE THERAPEUTICS, INC. | 1 | $116 |
| MERZ NORTH AMERICA, INC. | 1 | $114 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $77 |
| Merck Sharp & Dohme LLC | 2 | $58 |
| Shionogi Inc | 1 | $24 |
Products named: DAXXIFY, CAPLYTA, PREVYMIS, Fetroja.
Industry payments across NY — which companies pay providers there.
